Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pharmacists take on heart disease: new study tests community-based risk reduction

NCT ID NCT06405880

Ongoing Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle changes. The goal is to see if this approach lowers cardiovascular risk more than usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pharmacist-led care pathway

What this could lead to

If successful, this could show that pharmacist-led programs effectively reduce heart disease risk in the community.

What could go wrong

This is an implementation study, not a drug trial. Results depend on real-world adherence and may not apply to all settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis atherosclerosis cardiovascular disorder chronic kidney disease diabetes mellitus Dyslipidemias gout hypertensive disorder inflammatory disease inherited lipid metabolism disorder obesity disorder psoriasis psoriatic arthritis rheumatoid arthritis systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD PRESSURE CARDIOVASCULAR DISEASE CARDIOVASCULAR RISK FACTORS DIABETES DYSLIPIDEMIA

Contacts and locations

Locations

  • The University of Alberta

    Edmonton, Alberta, Canada